Hypoxia-induced proliferation in mesenchymal stem cells and angiotensin II-mediated PI3K/AKT pathway

Cell Biochemistry and Function

Volumn 33, Issue 2, 2015, Pages 51-58

  Zhang, Yujuan ^a   Lv, Juanxiu ^a   Guo, Hui ^a   Wei, Xiaoguang ^a   Li, Weisheng ^a   Xu, Zhice ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Hypoxia; Mesenchymal stem cell; PI3K; Proliferation

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; HYPOXIA INDUCIBLE FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 4; OXYGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR SOX2; VASCULOTROPIN A; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL HYPOXIA; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL CULTURE; MESENCHYMAL STROMA CELL; METABOLISM;

ANGIOTENSIN II; ANIMALS; CELL HYPOXIA; CELL PROLIFERATION; CELLS, CULTURED; MESENCHYMAL STROMAL CELLS; MICE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84924491480     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.3080     Document Type: Article

References (44)

1. Zhao YF, Zeng DL, Xia LG, et al. The Osteogenic potential of bone marrow stromal cells derived from streptozotocin-induced diabetic rats. Int J Mol Med 2013; 31: 614-620.
2. Pino AM, Rosen CJ, Rodríguez JP. In Osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis. Biol Res 2012; 45: 279-287.
3. Wei N, Yu Y, Schmidt T, Stanford C, Hong L. Effects of glucocorticoid receptor antagonist, RU486, on the proliferative and differentiation capabilities of bone marrow mesenchymal stromal cells in ovariectomized rats. J Orthop Res 2013; 31: 760-767.
4. Yew TL, Chang MC, Hsu YT, et al. Efficient expansion of mesenchymal stem cells from mouse bone marrow under hypoxic conditions. J Tissue Eng Regen Med 2013; 7: 984-993.
5. Mohyeldin A, Garzón-Muvdi T, Quiñones-Hinojosa A. Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 2010; 7: 150-161.
6. Potier E, Ferreira E, Meunier A, Sedel L, Logeart-Avramoglou D, Petite H. Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death. Tissue Eng 2007; 13: 1325-1331.
7. Deschepper M, Oudina K, David B, et al. Survival and function of mesenchymal stem cells (MSCs) depend on glucose to overcome exposure to long-term, severe and continuous hypoxia. Cell Mol Med 2011; 15: 1505-1514.
8. Lavrentieva A, Majore I, Kasper C, Hass R. Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells. Cell Commun Signal 2010; 8: 18-27.
9. Durik M, Sevá Pessôa B, Roks AJ. The renin-angiotensin system, bone marrow and progenitor cells. Clin Sci (Lond) 2012; 123: 205-223.
10. Matsushita K, Wu Y, Okamoto Y, Pratt RE, Dzau VJ. Local Renin Angiotensin Expression Regulates Human Mesenchymal Stem Cell Differentiation to Adipocytes. Hypertension 2006; 48: 1095-1102.
11. Bunni MA, Kramarenko II, Walker L, Raymond JR, Garnovskaya MN. Role of integrins in angiotensin II-induced proliferation of vascular smooth muscle cells. Am J Physiol Cell Physiol 2011; 300: 647-656.
12. Strawn WB, Richmond RS, Ann Tallant E, Gallagher PE, Ferrario CM. Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. Br J Haematol 2004; 126: 120-126.
13. Ebrahimian T, Neves MF, Offermanns S, Gonzalez FJ, Paradis P, Schiffrin EL. Protective Role of Vascular Smooth Muscle Cell PPARγ in Angiotensin II-induced Vascular Disease. Cardiovasc Res 2013; 97: 562-570.
14. Koh SL, Ager E, Malcontenti-Wilson C, Muralidharan V, Christophi C. Blockade of the renin-angiotensin system improves the early stages of liver regeneration and liver function. J Surg Res 2013; 179: 66-71.
15. Vlahakos DV, Marathias KP, Madias NE. The role of the renin-angiotensin system in the regulation of erythropoiesis. Am J Kidney Dis 2010; 56: 558-565.
16. Wang L, Zhao L, Zhang D, Chen JZ, Xue JL. Different effects of telmisartan and Valsartan on human aortic vascular smooth muscle cell proliferation. Chin Med J 2012; 125: 2200-2204.
17. Jung F, Haendeler J, Goebel C, Zeiher AM, Dimmeler S. Growth factor-induced phosphoinositide 3-OH kinase/Akt phosphorylation in smooth muscle cells: induction of cell proliferation and inhibition of cell death. Cardiovasc Res 2000; 48: 148-157.
18. Seo KW, Lee SR, Bhandari DR, et al. CT4A contributes to the stemness and multi-potency of human umbilical cord blood-derived multipotent stem cells (hUCB-MSCs). Biochem Biophys Res Commun 2009; 384: 120-125.
19. Fehrer C, Brunauer R, Laschober G, et al. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 2007; 6: 745-757.
20. Ding Y, Lv J, Mao C, et al. High-salt diet during pregnancy and angiotensin-related cardiac changes. J Hypertens 2010; 28: 1290-1297.
21. Yew TL, Huang TF, Ma HL, et al. Scale-up of MSC under hypoxic conditions for allogeneic transplantation and enhancing bony regeneration in a rabbit calvarial defect model. J Orthop Res 2012; 30: 1213-1220.
22. Pattappa G, Thorpe SD, Jegard NC, Heywood HK, Bruijn JD, Lee DA. Continuous and Uninterrupted Oxygen Tension Influences the Colony Formation and Oxidative Metabolism of Human Mesenchymal Stem Cells. Tissue Eng PT C-Meth 2013; 19: 68-79.
23. Holzwarth C, Vaegler M, Gieseke F, et al. Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol 2010; 11: 11-22.
24. Park IH, Kim KH, Choi HK, et al. Constitutive stabilization of hypoxia-inducible factor alpha selectively promotes the self-renewal of mesenchymal progenitors and maintains mesenchymal stromal cells in an undifferentiated state. Exp Mol Med 2013; 45: e44-55.
25. Chang W, Lee CY, Park JH, et al. Survival of hypoxic human mesenchymal stem cells is enhanced by a positive feedback loop involving miR-210 and hypoxia-inducible factor 1. Vet Sci 2013; 14: 69-76.
26. Fitzsimons JT. Angiotensin, thirst, and sodium appetite. Physiol Rev 1998; 78: 583-686.
27. Eguchi S, Inagami T. Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regul Pept 2000; 91: 13-20.
28. Horiuchi M, Iwanami J, Mogi M. Regulation of angiotensin II receptors beyond the classical pathway. Clin Sci (Lond) 2012; 123: 193-203.
29. Wang CH, Li F, Takahashi N. The renin angiotensin system and the metabolic syndrome. Open Hypertens J 2010; 3: 1-13.
30. Xue Q, Dasgupta C, Chen M, Zhang L. Foetal hypoxia increases cardiac AT(2)R expression and subsequent vulnerability to adult ischaemic injury. Cardiovasc Res 2011; 89: 300-308.
31. Chiu CZ, Wang BW, Chung TH, Shyu KG. Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytes. Clin Sci (Lond) 2010; 119: 273-282.
32. Yang W, Mao C, Xia F, et al. Changed salt appetite and central angiotensin II-induced cellular activation in rat offspring following hypoxia during fetal stages. Peptides 2010; 31: 1177-1183.
33. Wang X, Lu J, Khaidakov M, et al. Delineation of the effects of angiotensin type 1 and 2 receptors on HL-1 cardiomyocyte apoptosis. Apoptosis 2012; 17: 908-915.
34. Ager EI, Wen SW, Chan J, Chong WW, Neo JH, Christophi C. Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation. BMC Cancer 2011; 11: 274-286.
35. Borgatti P, Martelli AM, Bellacosa A, et al. Translocation of AKT/PKB to the nucleus of osteoblast-like MC3T3-E1 cells exposed to proliferative growth factors. FEBS Lett 2000; 477: 27-32.
36. Ushio-Fukai M, Alexander RW, Akers M, et al. Reactive oxygen species mediate the activation of AKT/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 1999; 274: 22699-22704.
37. Takahashi T, Taniguchi T, Konishi H, Kikkawa U, Ishikawa Y, Yokoyama M. Activation of AKT/protein kinase B after stimulation with angiotensin II in vascular smooth muscle cells. Am J Physiol 1999; 276: 1927-1934.
38. Gorin Y, Kim NH, Feliers D, Bhandari B, Choudhury GG, Abboud HE. Angiotensin II activates AKT/protein kinase B by an arachidonic acid/redox-dependent pathway and independent of phosphoinositide 3-kinase. FASEB J 2001; 15: 1909-1920.
39. Zhai P, Galeotti J, Liu J, et al. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy. Circ Res 2006; 99: 528-536.
40. Han HJ, Han JY, Heo JS, Lee SH, Lee MY, Kim YH. ANG II-stimulated DNA synthesis is mediated by ANG II receptor-dependent CA (2+)/PKC as well as EGF receptor-dependent PI3K/AKT/mTOR/p70S6K1 signal pathways in mouse embryonic stem cells. J Cell Physiol 2007; 211: 618-629.
41. Singh S, Trevino J, Singhal NB, et al. EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer. Mol Cancer 2012; 11: 73-88.
42. Yu KR, Yang SR, Jung JW, et al. CD49f enhances multipotency and maintains stemness through the direct regulation of OCT4 and SOX2. Stem Cells 2012; 30: 876-887.
43. Alvarez-Tejado M, Naranjo-Suarez S, Jiménez C, Carrera AC, Landázuri MO, Del Peso L. Hypoxia induces the activation of the phosphatidylinositol 3-kinase/AKT cell survival pathway in PC12 cells: protective role in apoptosis. J Biol Chem 2001; 276: 22368-22374.
44. Alvarez-Tejado M, Alfranca A, Aragonés J, Vara A, Landázuri MO, del Peso L. Lack of evidence for the involvement of the phosphoinositide 3-kinase/AKT pathway in the activation of hypoxia-inducible factors by low oxygen tension. J Biol Chem 2002; 277: 13508-13517.